UDG Healthcare Public Limited Co. Notice of Interim Results (1320W)

TIDMUDG

RNS Number : 1320W

UDG Healthcare Public Limited Co.

25 April 2016

25 April 2016

UDG Healthcare plc

Notice of Interim Results

UDG Healthcare plc ("the Company"), a leading international healthcare services provider, will issue its interim results for the half year ended 31 March 2016 at 07:00am (BST) on Thursday 19 May 2016.

The Company will be hosting an analyst and investor presentation at the London Stock Exchange at 09:00am (BST) on Thursday 19 May 2016. Analysts and investors wishing to attend are asked to contact Powerscourt on the details below. The presentation will also be available via live audio webcast and conference call, the details of which are below.

Audio webcast:

http://edge.media-server.com/m/p/3w8qtbpi

Conference call dial-in details:

 
 UK                          + 44-203-427-1907 
--------------------------  ------------------ 
 Ireland                     + 353-1-246-5601 
--------------------------  ------------------ 
 United States of America    + 1-212-444-0412 
--------------------------  ------------------ 
 Participant Code            9775904 
--------------------------  ------------------ 
 

For further information, please contact:

 
 UDG Healthcare plc 
  Keith Byrne 
 Head of Investor Relations 
  and Strategy 
 Tel: + 353-1-463-7722 
 
 Powerscourt 
 Lisa Kavanagh / Jack Hickey 
 Tel: [phone] 
  [e-mail] 
 

About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international provider of services to the healthcare industry, employing over 7,000 employees at operations across 19 countries including the US, UK, Ireland and Germany.

UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services.

Ashfield Commercial & Medical Services is a global leader in the provision of sales, marketing and healthcare communications services to pharmaceutical companies. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle enabling improved compliance and clinical outcomes. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in 18 countries.

Sharp Packaging Services is a global leader in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

Supply Chain Services consists of Aquilant, a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information please go to: www.udghealthcare.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORSESFMEFMSEFL

(END) Dow Jones Newswires

April 25, 2016 02:01 ET (06:01 GMT)